Furthermore, the binding of EZH2 and H3K27me3 to the promoter of APC leads to its inhibition, thereby contributing to the accumulation of tumor stem cells and the development of chemotherapy resistance [63, 85–87]. The gene discussed is EZH2; the disease is neoplasm.